Table 4 Comparison of clinical characteristics between caveolin-1 low and high expression groups.

From: Caveolin-1 inhibits the proliferation and invasion of lung adenocarcinoma via EGFR degradation

Clinical characteristics

Caveolin-1 low expression group (n = 14)

Caveolin-1 high expression group (n = 76)

χ2

P value

Age (years)

  

0.048

0.827

≤50

2

16

  

>50

12

60

  

Gender

  

0.074

0.786

 Male

7

41

  

Female

7

35

  

Pathological grade

  

0.872

0.350

 1–2

8

56

  

3

6

20

  

T grade

  

< 0.001

1

T1-2

12

68

  

 T3-4

2

8

  

N grade

  

2.324

0.127

 N0

6

49

  

 N1-3

8

27

  

Clinical stage

  

0.026

0.873

 I-II

10

59

  

 III-IV

4

17

  
Back to article page